|
Medical Technology News
Recent News Stories from PRnetwire.com >> News Article
Edited by Christopher Simmons, senior news editor
DIRECT WIRELESS ENTERS INTO A LETTER OF AGREEMENT TO ACQUIRE FRACTAL GENOMICS
SAN FRANCISCO, CALIF. - September 2, 2003 (Send2Press Newswire) -- Direct
Wireless Communications, Inc. (OTCBB: DWCM) today announced the signing of
a binding Letter of Agreement to acquire Fractal Genomics in San
Francisco, California. Fractal Genomics was founded by Sandy Shaw, a
former bioinformatics specialist at the University of California, San
Francisco and former computer scientist and software engineer with over
twenty years of experience at Bell Labs, Lockheed Electronics and the
University of Hawaii.
Fractal Genomics utilizes its patent protected technology to find, link
and model patterns of similarity hidden in large amounts of information,
such as the clinical databases used for diagnostic and drug discovery and
has patent protected protein and pathway discovery in leukemia and lung
development, which could lead to the identification of novel proteins that
could be used to develop diagnostic markers and drug targets.
"We are extremely pleased to have signed a binding Letter of Agreement to
acquire the patent protected computational software used in diagnosis and
drug discovery developed by Fractal Genomics," stated Bill G. Williams,
Chief Executive Officer of Direct Wireless. "Fractal Genomics has
successfully used its Fractal Genomics Modeling (FGM) software to analyze
databases from MD Anderson Cancer Center, St. Jude Children's Hospital and
the Alvin J. Siteman Cancer Center at Washington University. We are also
pleased to have Mr. Shaw serve as the Vice-President and Director of
Fractal Based Information Technology."
"I am looking forward to joining the impressive and accomplished
scientific staff at Direct Wireless," remarked Sandy Shaw, founder of
Fractal Genomics. "I welcome the opportunity to work closely with
pharmaceutical and diagnostic companies worldwide to assist them in
identifying novel proteins and pathways critical to diagnosing and
treating patients with devastating diseases like cancer, heart disease,
obesity and AIDS."
For more information, visit http://www.FractalGenomics.com
Company Website:
www.FractalGenomics.com
Source of News:
Direct Wireless Communications, Inc.
Stock Info on Yahoo!® Finance BB: DWCM
California Business News
/
Medical Technology Newswire
> Read original news release in raw text format
> Previous News from Direct Wireless Communications, Inc.
> More Medical Technology News
> More California Business News
> Other Recent News Stories
FOR INFORMATION ABOUT THE COMPANY OR ORGANIZATION(S) MENTIONED IN THE ABOVE NEWS ITEM, PLEASE CONTACT THE COMPANY DIRECTLY. SEND2PRESS/NEOTROPE IS NOT A REPRESENTATIVE OF, AND DOES NOT OFFER FURTHER INFORMATION ABOUT, ANY COMPANY MENTIONED IN THE ABOVE NEWS ITEM.
DISCLAIMER: the above news article is believed accurate but not guaranteed, and is based on news supplied by the company or organization mentioned and/or quoted in the story. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news item are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope/Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. Reproduction of this news article in any form requires written authorization — use of the raw text version of the news has no restrictions other than you may not post our news on a website which offers either PR or newswire services, or Internet Promotion services.. You may freely link to this article. eNewsChannels™ (www.eNewsChannels.com) is a unit of Neotrope®. Keyword marketing technology by DotComMojo™, a unit of Neotrope.
NEWSWIRE TERMS OF USE
|
